All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.


Drug Profile of Dasatinib

Author(s): Suresh M, Kavya R, Naveen R, Karthik M

Many patients find it difficult to swallow tablets and hard gelatin capsules and thus not comply with prescription that results in high incidence of non-compliance and ineffective therapy. Immediate release tablets are gaining prominence as new drug delivery systems. These dosage forms dissolve or disintegrate in oral cavity within a minute without the need of water or chewing. In this study, an effort has been made to formulate immediate release tablets using different disintegrants drug. Considering the merits of Dasatinib, we are proposing to choose it as an anticancer drug.

Share this       
Get the App